UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

CD4 + T cell help creates memory CD8 + T cells with innate and help-independent recall capacities

Nature communications, 2019-12, Vol.10 (1), p.5531-13, Article 5531

2019

Volltextzugriff (PDF)

The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

Nature communications, 2021-01, Vol.12 (1), p.401-15, Article 401

2021

Volltextzugriff (PDF)

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

Oncogene, 2018-08, Vol.37 (33), p.4611-4625

2018

Volltextzugriff (PDF)

Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors

Cancer cell, 2019-12, Vol.36 (6), p.674-689.e6

2019

Volltextzugriff (PDF)

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer

Nature communications, 2020-01, Vol.11 (1), p.441-13, Article 441

2020

Volltextzugriff (PDF)

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting

Breast cancer research : BCR, 2017-08, Vol.19 (1), p.99-9, Article 99

2017

Volltextzugriff (PDF)

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

Nature communications, 2018-02, Vol.9 (1), p.482-12, Article 482

2018

Volltextzugriff (PDF)

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer

Nature communications, 2021-11, Vol.12 (1), p.6377-6377, Article 6377

2021

Volltextzugriff (PDF)

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential

Nature communications, 2022-11, Vol.13 (1), p.7367-16, Article 7367

2022

Volltextzugriff (PDF)

The MSP‐RON axis stimulates cancer cell growth in models of triple negative breast cancer

Molecular oncology, 2020-08, Vol.14 (8), p.1868-1880

2020

Volltextzugriff (PDF)

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

Breast cancer research : BCR, 2014-01, Vol.16 (1), p.R13-R13, Article R13

2014

Volltextzugriff (PDF)

Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases

Molecular oncology, 2021-07, Vol.15 (7), p.1942-1955

2021

Volltextzugriff (PDF)

A review of estrogen receptor/androgen receptor genomics in male breast cancer

Endocrine-related cancer, 2017-03, Vol.24 (3), p.R27-R34

2017

Volltextzugriff (PDF)

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs

European urology, 2023-11, Vol.84 (5), p.455-460

2023

Volltextzugriff (PDF)

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial

NPJ breast cancer, 2017-08, Vol.3 (1), p.31-9, Article 31

2017

Volltextzugriff (PDF)

BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential

Molecular oncology, 2015-10, Vol.9 (8), p.1528-1538

2015

Volltextzugriff (PDF)

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment

Breast cancer research : BCR, 2014-01, Vol.16 (1), p.R6-R6, Article R6

2014

Volltextzugriff (PDF)

Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation

Oncotarget, 2016-06, Vol.7 (23), p.33901-33918

2016

Volltextzugriff (PDF)

Frequent mutation of histone―modifying genes in non―Hodgkin lymphoma

Nature (London), 2011-08, Vol.476 (7360), p.298-303

2011

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(46)

Sprache

Englisch
(46)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(27)
Life Sciences & Biomedicine
(23)
Oncology
(16)
Male
(14)
Female
(13)
Mutation
(13)
Tumors
(13)
Cell Line, Tumor
(10)
Gene Expression
(10)
Breast Cancer
(8)
Multidisciplinary Sciences
(8)
Prostate Cancer
(8)
Science & Technology - Other Topics
(8)
Aged
(7)
Gene Expression Regulation, Neoplastic
(7)
Genetic Aspects
(7)
Genomes
(7)
Androgen Receptors
(6)
Androgens
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CD4 + T cell help creates memory CD8 + T cells with innate and help-independent recall capacities

The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors

Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival

Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all- trans retinoic acid in acute myeloid leukemia across subtypes

The BRCA1ness signature is associated significantly with response to PARP inhibitor treatment versus control in the I-SPY 2 randomized neoadjuvant setting

Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential

The MSP‐RON axis stimulates cancer cell growth in models of triple negative breast cancer

PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients

Epigenetic and transcriptional analysis reveals a core transcriptional program conserved in clonal prostate cancer metastases

A review of estrogen receptor/androgen receptor genomics in male breast cancer

Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin

Grade Group 1 Prostate Cancers Exhibit Tumor-defining Androgen Receptor–driven Programs

Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence

DNA repair deficiency biomarkers and the 70-gene ultra-high risk signature as predictors of veliparib/carboplatin response in the I-SPY 2 breast cancer trial

BRCA1-like signature in triple negative breast cancer: Molecular and clinical characterization reveals subgroups with therapeutic potential

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment

Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects in vitro and poor outcome in patients with advanced head and neck squamous cell carcinoma

Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation

Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms

Frequent mutation of histone―modifying genes in non―Hodgkin lymphoma

Suchergebnisse filtern